Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATG for GVHD Prophylaxis in MSD-PBSCT
NCT02677181Phase 4Completed
- Sponsor
- Chinese PLA General Hospital
- Start
- Jan 2016
- Primary completion
- Jan 2020
- Modality
- Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of antithymocyte globulin rabbit in graft-versus-host disease (GVHD), sponsored by Chinese PLA General Hospital. Started Jan 2016; status: completed.
02
Drugs
antithymocyte globulin rabbit
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT02677181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02677181.